Canakinumab is a human monoclonal antibody directed against interleukin 1 beta (IL1B). Canakinumab is being used in the treatment of of cryopyrin-associated periodic syndromes (CAPS).

What can Sanquin do for you?

  • Measure drug levels of free drug in the serum using an validated ELISA.
  • Measure the immunogenicity of canakinumab.
  • Provide assay reagents or co-develop novel testing strategies.
  • Folllowing ISO, FDA/EMA, RUO guidelines.

Enquire about our drug level and ADA assays by emailing us at [email protected]